4//SEC Filing
Wise John Drayton 4
Accession 0001628280-24-000698
CIK 0001104506other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:33 PM ET
Size
15.2 KB
Accession
0001628280-24-000698
Insider Transaction Report
Form 4
INSMED IncINSM
Wise John Drayton
Chief Commercial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-01-03$19.11/sh+20,071$383,557→ 124,055 total - Sale
Common Stock
2024-01-05$29.32/sh−1,167$34,216→ 115,690 total - Award
Common Stock
2024-01-04+12,873→ 116,857 total - Sale
Stock Option (right to buy)
2024-01-03$29.19/sh−20,071$585,872→ 103,984 total - Award
Stock Option (right to buy)
2024-01-04+63,560→ 63,560 totalExercise: $29.13Exp: 2034-01-04→ Common Stock (63,560 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-01-03−20,071→ 0 totalExercise: $19.11Exp: 2024-02-10→ Common Stock (20,071 underlying)
Footnotes (8)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
- [F3]This is the weighted average sales price representing 20,071 shares sold at prices ranging from $28.915 to $29.39 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F4]Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.
- [F5]Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.
- [F6]Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
- [F7]Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.
- [F8]Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.
Documents
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001930805
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:33 PM ET
- Size
- 15.2 KB